The company said the 'password era is ending'.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).
Haiwainet, the website of the overseas edition of the People's Daily, today reported, the 4th China-Africa Economic and Trade Expo (CAETE), themed “China and Africa: Together Toward Modernization”, was successfully held in Changsha, capital of central China's Hunan Province.
